[<i>Qingjie Fuzheng</i> Granules alleviates 5-fluorouracil-induced skeletal muscle injury in tumor-bearing mice by inhibiting mitochondria-dependent apoptosis and activating the AMPK-PGC-1α pathway]. [PDF]
Zhao J +5 more
europepmc +1 more source
[ZEB2 promotes glioblastoma progression by reprogramming lipid metabolism through the CYLD/FASN axis]. [PDF]
Chen Z, Chai P, Mao Y, Liu R, Song Y.
europepmc +1 more source
一种含β沸石的催化剂,其组成为:重量比30-90%的β沸石和重量比10-70%的无机粘结剂,其中β沸石的SiO2/Al2O3为15-60;其中无机粘结剂为氧化铝。制备方法为:将合成的β沸石原粉与无机粘结剂的前身物、硝酸和去离子水混捏成型,干燥后450-550℃空气中烧去模板剂,80-90℃铵盐水溶液交换,于500-600℃焙烧脱氨1-5小时,250-400℃用水蒸气处理0.5-10小时,即得催化剂;其中铵盐为NH4Cl、(NH4)2SO4或NH4NO3;无机粘结剂的前身物为拟薄水铝石 ...
孙新德 +3 more
core
[Poricoic acid A alleviates dextran sulfate sodium-induced colitis in mice by regulating AMPK/mTOR-mediated autophagy and inhibiting intestinal epithelial cell apoptosis]. [PDF]
Qiao T +7 more
europepmc +1 more source
考察了担载MoO3的沸石催化剂上甲烷的无氧芳构化性能,并与沸石结构相关联。结果表明,孔径与苯分子动态直径相当的ZSM-5、ZSM-8、ZSM-11和β沸石等是甲烷无氧芳构化催化剂的良好载体,其中3%MoO3/HZSM-11具有最高的甲烷芳构化活性和稳定性,973K下的转化HMCM-41和HSAPO-34为载体时芳构化活化很低,以HMOR、HX和HY为载体时仅有少量乙烯生成,而以HSAPO ...
张春雷 +6 more
core
[<i>Jia Wei Qingxin</i> Lotus Seed Drink improves diabetic kidney disease in mice by regulating the KDM3C/SP1 signaling pathway]. [PDF]
Xie J, Luo Y, Xia J, Wang M.
europepmc +1 more source
提出了应用高效NaY沸石导向剂快速合成A型沸石的新方法.在合成过程中,NaY沸石导向剂提供了全部硅源(无需另加硅源).与用水玻璃提供硅源的合成方法相比,该法晶化速度快,合成温度低,并可在低碱度条件下合成超细A型沸石29SiNMR表征和UV Raman研究表明,高效NaY沸石导向剂中含有大量的六元环等低分子量硅铝酸根前驱体 ...
范峰滔 +8 more
core
[Verbenalin ameliorates intestinal inflammation and colitis in a mouse model of Crohn's disease by inhibiting the PI3K-AKT pathway]. [PDF]
Huang L +8 more
europepmc +1 more source
一种用于由多乙基苯和苯生产乙苯用的催化剂,由SiO2/Al2O3摩尔比为25~60的β沸石、卤素和惰性组份构成,其中β沸石重量范围为50~90%,卤素原子数为每克催化剂0.1~1.6×1020个,其余为惰性组份。该催化剂的酸性质是每克催化剂总酸量为(150~600℃氨脱附对应酸中心)5×1020~15×1020个,其中中强酸中心(330~600℃氨脱附)和弱酸中心(150~330℃氨脱附)的比例为65∶35~35∶65。该催化剂用于多乙基苯和苯液相烷基转移反应生产乙苯过程具有较高的选择性 ...
徐龙伢 +4 more
core
[Modified <i>Gandou</i> Decoction improves cognitive function of TX mice with Wilson's disease by inhibiting the PKR/eIF2α pathway]. [PDF]
Xu C, Han Y, Cheng N, Dong J.
europepmc +1 more source

